In 2009, the School established the Centre for Cancer and Inflammation Research (CCIR), which sets out to search for the causes of cancer and inflammatory conditions as well as novel therapeutic strategies by combining Chinese medicine and modern scientific technology, with the aim of pursuing innovative research in contributing to the health of human kind.

Riding on the rapid development of Chinese medicine, the Centre concentrates its research on the most commonly occurring types of cancers and inflammatory conditions in Hong Kong, such as lung cancer, breast cancer, colorectal cancer and rheumatoid arthritis, by leveraging on the experts, resources and facilities of the School as well as the strengths of collaborative institutions locally and abroad. The Centre is honoured to have invited a number of renowned scholars to serve as academic advisors to jointly set up a platform for international collaborations on anti-cancer and anti-inflammation research.